Carcinomas, which constitute about 80 percent of all human cancers, arise as a malignant transformation of epithelial cells. To elucidate the pathophysiology of epithelial cell transformation, we have established a unique in vitro model, in which a single oncogene, the HPV16 E6, induces a highly efficient immortalization of normally senescent human mammary epithelial cells. Using this model, we have demonstrated that the loss of function of p53 tumor suppressor protein is essential for immortalization but is not sufficient, suggesting that additional cellular targets are involved in E6-induced immortalization. Using the yeast two-hybrid interaction system, we have isolated one such cellular protein that binds to and is targeted for degradation by the immortalization-competent but not immortalization-incompetent HPV16 E6 protein. This novel protein, designated E6TP1 (E6-targeted protein 1) exhibits high homology to GTPase-activating proteins for the Ras-related small G-proteins of the Rap family. We hypothesize that a loss of E6TP1 function constitutes one of the lesions in epithelial cell immortalization. Here, we propose analyses to examine the basis of a functional role of E6TP1 in epithelial cell transformation. We will develop anti-E6TP1 antibodies and use these to characterize the E6TP1 polypeptide(s) in relation to cellular proliferation, senescence and cell cycle and delineate the mechanism of E6-targeted degradation of E6TP1; assess the potential growth inhibitory/tumor suppressor function of E6TP1; perform mutational analyses to define the functionally critical domains of E6TP1 and characterize the GAP activity of E6TP1 protein. Characterization of this novel putative mediator of epithelial oncogenesis represents a step forward in our understanding of the pathophysiology of carcinomas and may aid in future design of novel molecular therapeutics against carcinomas.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA081076-01
Application #
2828533
Study Section
Pathology B Study Section (PTHB)
Program Officer
Wong, May
Project Start
1999-09-08
Project End
2004-06-30
Budget Start
1999-09-08
Budget End
2000-06-30
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Tufts University
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02111
Bailey, Tameka A; Luan, Haitao; Clubb, Robert J et al. (2011) Mechanisms of Trastuzumab resistance in ErbB2-driven breast cancer and newer opportunities to overcome therapy resistance. J Carcinog 10:28
Ortega-Cava, Cesar F; Raja, Srikumar M; Laiq, Zenab et al. (2011) Continuous requirement of ErbB2 kinase activity for loss of cell polarity and lumen formation in a novel ErbB2/Neu-driven murine cell line model of metastatic breast cancer. J Carcinog 10:29
George, Manju; Rainey, Mark A; Naramura, Mayumi et al. (2010) Ehd4 is required to attain normal prepubertal testis size but dispensable for fertility in male mice. Genesis 48:328-42
Standley, Stephany M; Toft, Daniel J; Cheng, Hao et al. (2010) Induction of cancer cell death by self-assembling nanostructures incorporating a cytotoxic peptide. Cancer Res 70:3020-6
Rainey, Mark A; George, Manju; Ying, GuoGuang et al. (2010) The endocytic recycling regulator EHD1 is essential for spermatogenesis and male fertility in mice. BMC Dev Biol 10:37
Kim, Jun Hyun; Gurumurthy, Channabasavaiah Basavaraju; Band, Hamid et al. (2010) Biochemical characterization of human Ecdysoneless reveals a role in transcriptional regulation. Biol Chem 391:9-19
Tu, Chun; Ortega-Cava, Cesar F; Winograd, Paul et al. (2010) Endosomal-sorting complexes required for transport (ESCRT) pathway-dependent endosomal traffic regulates the localization of active Src at focal adhesions. Proc Natl Acad Sci U S A 107:16107-12
Chung, B M; Dimri, M; George, M et al. (2009) The role of cooperativity with Src in oncogenic transformation mediated by non-small cell lung cancer-associated EGF receptor mutants. Oncogene 28:1821-32
Chung, Byung Min; Raja, Srikumar M; Clubb, Robert J et al. (2009) Aberrant trafficking of NSCLC-associated EGFR mutants through the endocytic recycling pathway promotes interaction with Src. BMC Cell Biol 10:84
Raja, Srikumar M; Clubb, Robert J; Bhattacharyya, Mitra et al. (2008) A combination of Trastuzumab and 17-AAG induces enhanced ubiquitinylation and lysosomal pathway-dependent ErbB2 degradation and cytotoxicity in ErbB2-overexpressing breast cancer cells. Cancer Biol Ther 7:1630-40

Showing the most recent 10 out of 33 publications